Markets

Latest News

Markets & Economy

The Mirage of Prosperity: Unmasking America’s Economic Deception

The notion that America enjoys a robust economy and soaring markets feels like mockery to most citizens. Investment professional Michael W. Green recently attempted to quantify the economic hardship experienced by ordinary Americans through his series examining widespread financial distress. This destruction has been justified by technocrats who use economic

Technology

Cloudflare vs. Italy: The High-Stakes Battle for Digital Freedom and Censorship Reform

A significant confrontation is unfolding between Cloudflare, a major internet infrastructure company, and Italian regulatory authorities over internet censorship and digital freedom. The dispute centers on Italy’s demand that Cloudflare participate in a content blocking system, which the company’s leadership characterizes as censorship without due process. Matthew Prince,

Markets & Economy

Guyana: The New Keystone in U.S. Strategy Amidst Venezuelan Turmoil

While international attention remains fixed on Venezuela following the dramatic capture of Nicolás Maduro by U.S. forces on January 3, a crucial development involving neighboring Guyana deserves closer examination. This small Caribbean nation has quietly positioned itself as a pivotal player in the Trump administration’s regional strategy. In

Markets & Economy

America’s Overlooked Crisis: Why Domestic Issues Demand Urgent Attention

The United States finds itself confronting an array of serious domestic challenges, yet the question remains: why aren’t these pressing issues receiving primary attention? With American households carrying debt exceeding 18 trillion dollars and federal obligations surpassing 38 trillion dollars, the nation’s financial resources are severely constrained. Despite

Purple Biotech Is Building Next-Generation Cancer Immunotherapy in a Space Where Deals Are Measured in Billions (NASDAQ: PPBT)
Wall Street Wire

Purple Biotech Is Building Next-Generation Cancer Immunotherapy in a Space Where Deals Are Measured in Billions (NASDAQ: PPBT)

Purple Biotech’s CAPTN-3 platform uses conditionally activated tri-specific antibody technology, part of a broader class of multispecific antibodies that has commanded $700 million+ upfront payments and multi-billion-dollar transactions across the pharmaceutical industry – yet the company trades at a single-digit-million valuation (NASDAQ: PPBT). For